In the context of estrogen receptor positive (ER+) breast cancer, it has been shown that CDK8 inhibition suppressed estrogen induced gene transcription through reduced RNAPII phosphorylation, suggesting a potential role of CDK8 inhibitors with antiestrogen therapy [29]. Here, CDK8 is linked to breast carcinoma.